BTK Inhibition as an MS Treatment Strategy ΡΠΊΠ°ΡΠ°ΡΡ Π² Ρ ΠΎΡΠΎΡΠ΅ΠΌ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅
BTK Inhibition as an MS Treatment Strategy
1 month ago
CME
meded
neurology
multiple sclerosis
MS
BTK inhibitor
interferon Ξ²-1a
progression independent of relapse activity
PIRA
relapse-associated worsening
RAW
smoldering inflammation
neuroinflammation
disability accrual
microglial activation
CNS- compartmentalized B cells
myeloid cells
ocrelizumab
evobrutinib
tolebrutinib
fenebrutinib
teriflunomide
remibrutinib
diroximel fumarate
anti-CD20
OPERA I
OPERA II
evolutionRMS 1
evolutionRMS 2
HERCULES
GEMINI 1
GEMINI 2
FENopta
ΠΠ΅ ΡΠ΄Π°Π΅ΡΡΡ Π·Π°Π³ΡΡΠ·ΠΈΡΡ Youtube-ΠΏΠ»Π΅Π΅Ρ. ΠΡΠΎΠ²Π΅ΡΡΡΠ΅ Π±Π»ΠΎΠΊΠΈΡΠΎΠ²ΠΊΡ Youtube Π² Π²Π°ΡΠ΅ΠΉ ΡΠ΅ΡΠΈ.
ΠΠΎΠ²ΡΠΎΡΡΠ΅ΠΌ ΠΏΠΎΠΏΡΡΠΊΡ...
ΠΠΎΠ²ΡΠΎΡΡΠ΅ΠΌ ΠΏΠΎΠΏΡΡΠΊΡ...
Π‘ΠΊΠ°ΡΠ°ΡΡ Π²ΠΈΠ΄Π΅ΠΎ Ρ ΡΡΡΠ± ΠΏΠΎ ΡΡΡΠ»ΠΊΠ΅ ΠΈΠ»ΠΈ ΡΠΌΠΎΡΡΠ΅ΡΡ Π±Π΅Π· Π±Π»ΠΎΠΊΠΈΡΠΎΠ²ΠΎΠΊ Π½Π° ΡΠ°ΠΉΡΠ΅: BTK Inhibition as an MS Treatment Strategy Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ 4k
Π£ Π½Π°Ρ Π²Ρ ΠΌΠΎΠΆΠ΅ΡΠ΅ ΠΏΠΎΡΠΌΠΎΡΡΠ΅ΡΡ Π±Π΅ΡΠΏΠ»Π°ΡΠ½ΠΎ BTK Inhibition as an MS Treatment Strategy ΠΈΠ»ΠΈ ΡΠΊΠ°ΡΠ°ΡΡ Π² ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΌ Π΄ΠΎΡΡΡΠΏΠ½ΠΎΠΌ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅, Π²ΠΈΠ΄Π΅ΠΎ ΠΊΠΎΡΠΎΡΠΎΠ΅ Π±ΡΠ»ΠΎ Π·Π°Π³ΡΡΠΆΠ΅Π½ΠΎ Π½Π° ΡΡΡΠ±. ΠΠ»Ρ Π·Π°Π³ΡΡΠ·ΠΊΠΈ Π²ΡΠ±Π΅ΡΠΈΡΠ΅ Π²Π°ΡΠΈΠ°Π½Ρ ΠΈΠ· ΡΠΎΡΠΌΡ Π½ΠΈΠΆΠ΅:
-
ΠΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ ΠΏΠΎ Π·Π°Π³ΡΡΠ·ΠΊΠ΅:
Π‘ΠΊΠ°ΡΠ°ΡΡ mp3 Ρ ΡΡΡΠ±Π° ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠΌ ΡΠ°ΠΉΠ»ΠΎΠΌ. ΠΠ΅ΡΠΏΠ»Π°ΡΠ½ΡΠΉ ΡΠΈΠ½Π³ΡΠΎΠ½ BTK Inhibition as an MS Treatment Strategy Π² ΡΠΎΡΠΌΠ°ΡΠ΅ MP3:
ΠΡΠ»ΠΈ ΠΊΠ½ΠΎΠΏΠΊΠΈ ΡΠΊΠ°ΡΠΈΠ²Π°Π½ΠΈΡ Π½Π΅
Π·Π°Π³ΡΡΠ·ΠΈΠ»ΠΈΡΡ
ΠΠΠΠΠΠ’Π ΠΠΠΠ‘Π¬ ΠΈΠ»ΠΈ ΠΎΠ±Π½ΠΎΠ²ΠΈΡΠ΅ ΡΡΡΠ°Π½ΠΈΡΡ
ΠΡΠ»ΠΈ Π²ΠΎΠ·Π½ΠΈΠΊΠ°ΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΡΠΎ ΡΠΊΠ°ΡΠΈΠ²Π°Π½ΠΈΠ΅ΠΌ Π²ΠΈΠ΄Π΅ΠΎ, ΠΏΠΎΠΆΠ°Π»ΡΠΉΡΡΠ° Π½Π°ΠΏΠΈΡΠΈΡΠ΅ Π² ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΡ ΠΏΠΎ Π°Π΄ΡΠ΅ΡΡ Π²Π½ΠΈΠ·Ρ
ΡΡΡΠ°Π½ΠΈΡΡ.
Π‘ΠΏΠ°ΡΠΈΠ±ΠΎ Π·Π° ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅ΡΠ²ΠΈΡΠ° ClipSaver.ru
BTK Inhibition as an MS Treatment Strategy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DWJ865. CME credit will be available until April 2, 2026. BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Sanofi. Disclosure information is available at the beginning of the video presentation.
Comments
![Upbeat Lofi - Deep Focus & Energy for Work [R&B, Neo Soul, Lofi Hiphop]](https://image.4k-video.ru/id-video/THh4fT0O7IY)
